AR021693A1 - 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS. - Google Patents

4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS.

Info

Publication number
AR021693A1
AR021693A1 ARP990106417A ARP990106417A AR021693A1 AR 021693 A1 AR021693 A1 AR 021693A1 AR P990106417 A ARP990106417 A AR P990106417A AR P990106417 A ARP990106417 A AR P990106417A AR 021693 A1 AR021693 A1 AR 021693A1
Authority
AR
Argentina
Prior art keywords
same
oxindoles
azolo
pharmaceutical composition
medicines
Prior art date
Application number
ARP990106417A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR021693A1 publication Critical patent/AR021693A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/04—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups one >CH- group, e.g. cyanines, isocyanines, pseudocyanines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

4,5-Azolo-oxindoles nuevos con la formula (1), donde: R1, R2, Y, Z y a tienen el significado indicado en la especificacion, inhiben las quinasasdependientes de ciclina (CDKs), en particular CDK2, y son utiles en el tratamiento o control de losdesord enes proliferativos celulares, en particularel cáncer. Composicion farmacéutica y usos.
ARP990106417A 1998-12-17 1999-12-15 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS. AR021693A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11261198P 1998-12-17 1998-12-17

Publications (1)

Publication Number Publication Date
AR021693A1 true AR021693A1 (es) 2002-07-31

Family

ID=22344875

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106417A AR021693A1 (es) 1998-12-17 1999-12-15 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS.

Country Status (18)

Country Link
EP (1) EP1149106B1 (es)
JP (1) JP2002532502A (es)
KR (2) KR100723854B1 (es)
CN (1) CN1159315C (es)
AR (1) AR021693A1 (es)
AT (1) ATE234839T1 (es)
AU (1) AU770060B2 (es)
BR (1) BR9916216A (es)
CA (1) CA2354852C (es)
DE (1) DE69906149T2 (es)
DK (1) DK1149106T3 (es)
ES (1) ES2192878T3 (es)
PE (1) PE20001329A1 (es)
PT (1) PT1149106E (es)
TR (1) TR200101745T2 (es)
UY (1) UY25855A1 (es)
WO (1) WO2000035920A2 (es)
ZA (1) ZA200104269B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
RU2006117635A (ru) 2003-10-24 2007-12-10 Шеринг Акциенгезельшафт (De) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
BRPI0608178A2 (pt) 2005-04-14 2009-11-17 Hoffmann La Roche derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
US9051263B2 (en) 2010-08-25 2015-06-09 Pacific Biosciences Of California, Inc. Functionalized cyanine dyes (PEG)
EP2850086B1 (en) * 2012-05-18 2023-07-05 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
KR101668074B1 (ko) * 2015-02-12 2016-10-21 전북대학교산학협력단 Ｐｋｒ 저해제를 유효성분으로 포함하는 기관지 천식의 예방 또는 치료용 조성물
US12097261B2 (en) 2021-05-07 2024-09-24 Kymera Therapeutics, Inc. CDK2 degraders and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984930B1 (en) * 1997-05-07 2005-04-06 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
BR9916216A (pt) 2001-09-11
KR100685192B1 (ko) 2007-02-22
AU3037200A (en) 2000-07-03
UY25855A1 (es) 2001-08-27
PE20001329A1 (es) 2000-12-11
ATE234839T1 (de) 2003-04-15
EP1149106A2 (en) 2001-10-31
DE69906149T2 (de) 2003-12-18
ES2192878T3 (es) 2003-10-16
CA2354852A1 (en) 2000-06-22
ZA200104269B (en) 2002-08-26
JP2002532502A (ja) 2002-10-02
KR20060109360A (ko) 2006-10-19
AU770060B2 (en) 2004-02-12
PT1149106E (pt) 2003-06-30
CN1159315C (zh) 2004-07-28
TR200101745T2 (tr) 2002-05-21
WO2000035920A3 (en) 2000-11-23
DK1149106T3 (da) 2003-07-14
CN1330654A (zh) 2002-01-09
DE69906149D1 (de) 2003-04-24
CA2354852C (en) 2008-09-23
WO2000035920A2 (en) 2000-06-22
EP1149106B1 (en) 2003-03-19
KR20010080768A (ko) 2001-08-22
KR100723854B1 (ko) 2007-05-31

Similar Documents

Publication Publication Date Title
AR004134A1 (es) Derivados 2-amino-6-anilino-purina y procedimiento y nuevos intermediarios para su preparacion, formulaciones farmaceuticas que comprenden talesderivados y el uso de estos derivados como medicamentos.
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
DE3883016D1 (de) Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
NO303780B1 (no) Nye 4-arylpiperaziner og 4-arylpiperidiner, sammensetning inneholdende dem samt deres anvendelse til fremstilling av terapeutikum
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
ECSP045410A (es) Nuevos derivados de piridazin-3(2h)-ona
SV1995000002A (es) Uso y obtencion de derivados tetraciclicos ref. 1233cv/vs
FI20011109A (fi) Bis-indolyylisukkiini-imidijohdannaiset ja niiden valmistus
AR024847A1 (es) 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento.
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
PA8432901A1 (es) Compuestos de piridilpirrol
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR021693A1 (es) 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR0114839A (pt) composição, e método de liberação de uma substáncia ou um material eletroprocessado em um local desejado
MX9401080A (es) Compuestos heteroaromaticos.
AR008781A1 (es) Compuestos de furano nitrona
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o

Legal Events

Date Code Title Description
FB Suspension of granting procedure